lwlagrange

SLNO - Extreme Oversold Territory Going Long...

Long
lwlagrange Updated   
NASDAQ:SLNO   Soleno Therapeutics, Inc.
SLNO - took a dive when the FDA demanded more testing of their latest drug. They are working on that and I suspect that we will see a retrace to 2.32 and possible sideways consolidation as the bulls sheepishly return to this little gem. I'm gonna run towards this as the bulls are running away. Be greedy when everyone else is afraid (Warren Buffet's play book) I'm going long! Price target of 2.32.
Comment:
They also reported positive earnings for the first time in a while so this looks pretty bullish to me.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.